---
title: "LiuXS Lab---Laboratory of Cancer Biology"
date: 2017-10-29
categories: Documentation
tags:
- lab
---



# LiuXS Lab---Laboratory of Cancer Biology 

## Introduction

**Xue-SongLiu lab** study the fundamental difference between ***cancer cell*** and ***normal somatic cell***. With a purpose to identify ***cancer specific biomarkers*** and ***therapeutic targets***. Multiple approaches, including cell ***biochemistry***, ***bioinformatics*** and ***mouse modeling***, are combined to investigate the basic mechanisms in cancer.

 

## Research projects

### 1. Cancer genetics and genomics

1. Using ***cell biochemistry*** and ***genetic engineered mouse models*** to study the function of **novel cancer related genes,** including *C7orf24/GGCT* and others 
2. ***Cancer genomic study*** to identify *novel features* and *novel driving alterations* for *cancer evolution*, with a specific focus on the function of ***non-coding DNA elements***. 



### 2. Cancer chromatin structure

Combing ***high throughput sequencing techniques*** (eg. Hi-C) and ***super-resolution microscope*** to study the ***chromatin structure alterations*** during the evolution of human cancer. 

##  

## Lab pictures

![](../images/LiuXSLab201707.jpg)

<p align="center">2017 07</p>


![](../images/LiuXSLab201709.jpg)

 <p align="center">2017 09</p>

## Publications

[17] Ming Chen, Jiangwen Zhang, Katia Sampieri, John G. Clohessy, Lourdes Mendez,Enrique Gonzalez-Billalabeitia, **Xue-SongLiu**, Yu-Ru Lee, Jacqueline Fung, Jesse M. Katon, Archita Venugopal Menon,Kaitlyn A. Webster, Christopher Ng, Maria Dilia Palumbieri , Moussa S.Diolombi, Susanne B. Breitkopf, Julie Teruya-Feldstein, Sabina Signoretti,Roderick T. Bronson, John M. Asara, Mireia Castillo-Martin, Carlos Cordon-Cardo,Pier Paolo Pandolfi. An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer. Nature Genetics. 2017 (Accepted).

[16] Gerarduzzi C, de Polo A, **Liu XS**, ElKharbili M, Little JB, Yuan ZM. Human epidermal growth factor receptor 4 (Her4)Suppresses p53 Protein via Targeting the MDMX-MDM2 Protein Complex: IMPLICATIONOF A NOVEL MDMX SER-314 PHOSPHOSITE. J Biol Chem. 2016 Dec9;291(50):25937-25949.  

[15] **Liu XS**, Liu Z, Gerarduzzi C, Choi DE, Ganapathy S, Pandolfi PP,Yuan ZM. Somatic human ZBTB7A zinc finger mutations promote cancer progression.Oncogene. 2015 Oct 12. doi: 10.1038/onc.2015.371.

[14] **Liu XS**\*, Chandramouly G, Rass E, Guan Y, Wang G, Hobbs RM,Rajendran A, Xie A, Shah JV, Davis AJ, Scully R, Lunardi A\*, Pandolfi PP. LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. Nature Communications. 2015 Oct 8; 6:8325. doi: 10.1038/ncomms9325. (\* co-first author)

[13] **Liu XS**, Genet MD, Haines JE, Mehanna EK, Wu S, Chen HI, Chen Y,Qureshi AA, Han J, Chen X, Fisher DE, Pandolfi PP, Yuan ZM. ZBTB7A suppresses melanoma metastasis by transcriptionally repressing MCAM. Mol Cancer Res. 2015,13(8):1206-17.

[12] **Liu XS**, Little JB, Yuan ZM. Glycolytic metabolism influences global chromatin structure. Oncotarget. 2015, 6(6):4214-25.

[11] **Liu XS**, Haines JE, Mehanna EK, GenetMD, Ben-Sahra I, Asara JM, Manning BD, Yuan ZM. ZBTB7A acts as a tumor suppressor through the transcriptional repression of glycolysis. Genes Dev.2014, 28(17):1917-28. (Highlighted in Nature Reviews Cancer: Isabel Lokody, Nature Reviews Cancer, 14, 649 (2014))  

[10] González-BillalabeitiaE, Seitzer N, Song SJ, Song MS, Patnaik A, **LiuXS**, Epping MT, Papa A, Hobbs RM, Chen M, Lunardi A, Ng C, Webster KA,Signoretti S, Loda M, Asara JM, Nardella C, Clohessy JG, Cantley LC, PandolfiPP. Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibition. Cancer Discov. 2014, 4(8):896-904. 

[9] Wang G, Lunardi A,Zhang J, Chen Z, Ala U, Webster KA, Tay Y, Gonzalez-Billalabeitia E, Egia A,Shaffer DR, Carver B, **Liu XS**, TaulliR, Kuo WP, Nardella C, Signoretti S, Cordon-Cardo C, Gerald WL, Pandolfi PP. Zbtb7asuppresses prostate cancer through repression of a Sox9-dependent pathway forcellular senescence bypass and tumor invasion. Nat Genet. 2013, 45(7):739-46. 

[8] Zhang HX, Liu ZX,Sun YP, Zhu J, Lu SY, **Liu XS**, HuangQH, Xie YY, Zhu HB, Dang SY, Chen HF, Zheng GY, Li YX, Kuang Y, Fei J, Chen SJ,Chen Z, Wang ZG. Rig-I regulates NF-κB activity through binding to Nf-κb13'-UTR mRNA. Proc Natl Acad Sci U S A. 2013, 110(16):6459-64. 

[7] **Liu XS**\*, Zhao XD\*, Wang X\*, Yao YX, Zhang LL, Shu RZ, Ren WH,Huang Y, Huang L, Gu MM, Kuang Y, Wang L, Lu SY, Chi J, Fen JS, Wang YF, Fei J,Dai W, Wang ZG. Germinal Cell Aplasia in Kif18a Mutant Male Mice Due to Impaired Chromosome Congression and Dysregulated BubR1 and CENP-E. Genes Cancer. 2010, 1(1):26-39. (\*co-first author) (Highlighted as cover story)

[6] Shu RZ, Zhang F, **Liu XS**, Li CL, Wang L, Tai YL, Wu XL,Yang X, Liao XD, Jin Y, Gu MM, Huang L, Pang XF, Wang ZG. Target deletion ofthe cytoskeleton-associated protein palladin does not impair neurite outgrowth in mice. PLoS One. 2009, 4(9):e6916. 

[5] Wu XL, Gu MM, HuangL, **Liu XS**, Zhang HX, Ding XY, Xu JQ,Cui B, Wang L, Lu SY, Chen XY, Zhang HG, Huang W, Yuan WT, Yang JM, Gu Q, FeiJ, Chen Z, Yuan ZM, Wang ZG. Multiple synostoses syndrome is due to a missen semutation in exon 2 of FGF9 gene. Am J Hum Genet. 2009, 85(1):53-63. 

[4] Wang Y, Zhang HX,Sun YP, Liu ZX, **Liu XS**, Wang L, LuSY, Kong H, Liu QL, Li XH, Lu ZY, Chen SJ, Chen Z, Bao SS, Dai W, Wang ZG. Rig-I-/-mice develop colitis associated with downregulation of G alpha i2. Cell Res.2007, 17(10):858-68.

[3] **Liu XS**, Li XH, Wang Y, Shu RZ, Wang L, Lu SY, Kong H, Jin YE,Zhang LJ, Fei J, Chen SJ, Chen Z, Gu MM, Lu ZY, Wang ZG. Disruption of palladin leads to defects in definitive erythropoiesis by interfering with erythroblastic island formation in mouse fetal liver. Blood. 2007, 110(3):870-76.

[2] **Liu XS**, Luo HJ, Yang H, Wang L, Kong H, Jin YE, Wang F, Gu MM, ChenZ, Lu ZY, Wang ZG. Palladin regulates cell and extracellular matrix interaction through maintaining normal actin cytoskeleton architecture and stabilizing beta1-integrin.J Cell Biochem. 2007, 100(5):1288-300.

[1] Luo H\*, **Liu X**\*, Wang F, Huang Q, Shen S, WangL, Xu G, Sun X, Kong H, Gu M, Chen S, Chen Z, Wang Z. Disruption of palladin results in neural tube closure defects in mice. Mol Cell Neurosci. 2005, 29(4):507-15.(\* co-first author)



**Resources**

Lab only

For public